HGH Holdings Ltd. (SGX:5GZ)
Singapore
· Delayed Price · Currency is SGD 0.0150
-0.0010 (-6.25%)
At close: Mar 26, 2025
HGH Holdings Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 21.32 | 20.03 | 21.59 | 20.07 | 11.7 | Upgrade
|
| Revenue Growth (YoY) | 6.43% | -7.20% | 7.56% | 71.60% | -51.06% | Upgrade
|
| Cost of Revenue | 15.22 | 16.25 | 17.75 | 15.52 | 8.04 | Upgrade
|
| Gross Profit | 6.11 | 3.78 | 3.84 | 4.55 | 3.65 | Upgrade
|
| Selling, General & Admin | 5.99 | 5.49 | 6.25 | 5.99 | 5.89 | Upgrade
|
| Other Operating Expenses | 0.35 | 0.01 | 0.11 | 0.94 | 0.94 | Upgrade
|
| Operating Expenses | 6.34 | 5.43 | 6.21 | 7.26 | 7.22 | Upgrade
|
| Operating Income | -0.24 | -1.65 | -2.38 | -2.71 | -3.57 | Upgrade
|
| Interest Expense | -0.28 | -0.16 | -0.17 | -0.17 | -0.18 | Upgrade
|
| Interest & Investment Income | 0.08 | 0.13 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.04 | -0.05 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.19 | 1.08 | 0.59 | 0.36 | 0.69 | Upgrade
|
| EBT Excluding Unusual Items | -0.25 | -0.64 | -2 | -2.52 | -3.06 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -2.51 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.13 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.03 | 0.22 | 0.14 | -0 | Upgrade
|
| Asset Writedown | - | - | - | -1.01 | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.37 | 0.89 | Upgrade
|
| Pretax Income | -0.25 | -0.61 | -1.78 | -3.02 | -4.81 | Upgrade
|
| Income Tax Expense | -0.1 | -0.28 | -0.27 | -0.73 | -0.56 | Upgrade
|
| Earnings From Continuing Operations | -0.15 | -0.32 | -1.51 | -2.29 | -4.25 | Upgrade
|
| Net Income to Company | -0.15 | -0.32 | -1.51 | -2.29 | -4.25 | Upgrade
|
| Minority Interest in Earnings | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Net Income | -0.13 | -0.31 | -1.5 | -2.27 | -4.24 | Upgrade
|
| Net Income to Common | -0.13 | -0.31 | -1.5 | -2.27 | -4.24 | Upgrade
|
| Shares Outstanding (Basic) | 1,250 | 1,781 | 1,781 | 1,781 | 1,781 | Upgrade
|
| Shares Outstanding (Diluted) | 1,250 | 1,781 | 1,781 | 1,781 | 1,781 | Upgrade
|
| Shares Change (YoY) | -29.81% | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -3.19 | 2.71 | -0.3 | 1.75 | 0.74 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.00 | - | 0.00 | - | Upgrade
|
| Gross Margin | 28.64% | 18.87% | 17.77% | 22.69% | 31.23% | Upgrade
|
| Operating Margin | -1.10% | -8.23% | -11.00% | -13.50% | -30.50% | Upgrade
|
| Profit Margin | -0.59% | -1.53% | -6.97% | -11.32% | -36.22% | Upgrade
|
| Free Cash Flow Margin | -14.95% | 13.53% | -1.41% | 8.70% | 6.31% | Upgrade
|
| EBITDA | 3.42 | 1.93 | 1.32 | 1.76 | 0.94 | Upgrade
|
| EBITDA Margin | 16.02% | 9.61% | 6.10% | 8.78% | 8.03% | Upgrade
|
| D&A For EBITDA | 3.65 | 3.57 | 3.69 | 4.47 | 4.51 | Upgrade
|
| EBIT | -0.24 | -1.65 | -2.38 | -2.71 | -3.57 | Upgrade
|
| EBIT Margin | -1.10% | -8.23% | -11.00% | -13.50% | -30.50% | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.